Prevalence of COVID-19 Antibodies Kingman AZ

CompletedOBSERVATIONAL

Enrollment

566

Participants

Timeline

Start Date

September 28, 2020

Primary Completion Date

October 9, 2020

Study Completion Date

May 1, 2021

Conditions

Covid19

Interventions

DIAGNOSTIC_TEST

VITROS Anti-SARS-CoV-2 IgG test

The VITROS Anti-SARS-CoV-2 IgG test is a lateral flow immunoassay produced by Ortho-Clinical Diagnostics Inc.

Trial Locations (1)

Kingman Regional Medical Center, Kingman

All Listed Sponsors

lead

Kingman Regional Medical Center

OTHER

NCT04533360 - Prevalence of COVID-19 Antibodies Kingman AZ | Biotech Hunter | Biotech Hunter